Halog
Loading...Halog Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For temporary relief of sinus congestion, hives, mood swings, fatigue, and chest congestion with constriction.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Halog Manufacturers
-
Ranbaxy Laboratories Inc.
![Halog (Halcinonide) Ointment [Ranbaxy Laboratories Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Halog | Apotheca Company
Directions: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
-
Ranbaxy Laboratories Inc
Halog | Ranbaxy Laboratories Inc
Apply the 0.1% HALOG (Halcinonide Cream, USP) to the affected area two to three times daily. Rub in gently.
Occlusive Dressing TechniqueOcclusive dressings may be used for the management of psoriasis or other recalcitrant conditions. Gently rub a small amount of cream into the lesion until it disappears. Reapply the preparation leaving a thin coating on the lesion, cover with a pliable nonporous film, and seal the edges. If needed, additional moisture may be provided by covering the lesion with a dampened clean cotton cloth before the nonporous film is applied or by briefly wetting the affected area with water immediately prior to applying the medication. The frequency of changing dressings is best determined on an individual basis. It may be convenient to apply HALOG under an occlusive dressing in the evening and to remove the dressing in the morning (i.e., 12-hour occlusion). When utilizing the 12-hour occlusion regimen, additional cream should be applied, without occlusion, during the day. Reapplication is essential at each dressing change.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
![Halog (Halcinonide Cream) Cream [Ranbaxy Laboratories Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e60d0691-0628-4c98-9a17-f4a89822baf2&name=label1.jpg)
Login To Your Free Account